Rodman David Malcom bought MLYS
February 17, 2026 · Form 4 insider transaction
Rodman David Malcom bought 417 shares of Mineralys Therapeutics, Inc. at $15.44 per share, a transaction worth $6.4K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
417
Price
$15.44
Total value
$6.4K
InsiderRodman David Malcom
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateFebruary 17, 2026
Filing dateFebruary 17, 2026
Shares owned after44,506
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025.